{"id":135652,"date":"2026-08-11T05:28:35","date_gmt":"2026-08-11T05:28:35","guid":{"rendered":"https:\/\/www.europesays.com\/ai\/135652\/"},"modified":"2026-08-11T05:28:35","modified_gmt":"2026-08-11T05:28:35","slug":"digital-science-connects-ai-agents-to-world-leading-research-data-with-new-dimensions-mcp-servers","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ai\/135652\/","title":{"rendered":"Digital Science Connects AI Agents to World-Leading Research Data with New Dimensions MCP Servers"},"content":{"rendered":"

Newswise \u2014 Digital Science, a leading technology company serving stakeholders across the research ecosystem, today announced the launch of new Model Context Protocol (MCP) servers for Dimensions<\/a>, giving enterprise AI agents direct, license-aligned access to one of the world’s largest interconnected global research databases.<\/p>\n

The new integrations comprise two purpose-built and complementary MCP servers<\/a>:<\/p>\n

Dimensions Semantic Search MCP, a concept-aware search layer built for precision retrieval across 40+ life science domainsDimensions Analytics MCP, which connects AI agents to 430M+ interconnected records spanning publications, grants, patents, clinical trials, datasets, and policy documents<\/p>\n

No other MCP integration in the research space comes close to the breadth of documents, content, and data available from the Dimensions MCP servers. For R&D teams, pharma and biotech organizations, and competitive intelligence professionals, this opens up AI-assisted analytics across one of the world’s most comprehensive linked views of global research activity, for discovery and analysis.<\/p>\n

Existing Dimensions API customers can connect immediately, with no additional license required.<\/p>\n

Research intelligence at the speed of AI workflows<\/p>\n

Enterprise R&D teams, pharma and biotech organizations, and competitive intelligence professionals face a persistent challenge: the AI agents they depend on for faster decisions typically draw on general-purpose training data that may be months or years out of date, lacks the depth of peer-reviewed research intelligence, and can\u2019t always be verified. These issues are compounded by AI hallucinations. Without access to verified, structured research data, agents may generate responses that sound authoritative but have no reliable source. Manual data aggregation from fragmented sources remains the default workaround, making the work time-intensive, error-prone, and difficult to scale.<\/p>\n

The Dimensions MCPs address this directly. By connecting AI agents to live, structured Dimensions data through the MCP standard \u2013 compatible with every major AI platform including Claude, ChatGPT, and Gemini \u2013 teams can automate research discovery, funding intelligence, and competitive landscape analysis without leaving the workflows they already use, and without custom integration work.<\/p>\n

Used together, the two MCPs give AI agents both the depth to find the precise evidence and the breadth to map the research landscape around it, all through a single Dimensions API connection.<\/p>\n

Dimensions Semantic Search MCP<\/p>\n

Dimensions Semantic Search MCP gives AI assistants the ability to search scientific literature the way expert scientists do \u2013 by meaning, not just keywords. The result is an AI that can answer complex life science questions with real precision and depth, across publications, patents, grants, and clinical trials.<\/p>\n

Surface relevant evidence across drug classes, disease subtypes, and compound families automaticallyReveal which drugs, diseases, and compounds appear together across millions of documents \u2013 accelerating drug-disease mapping, safety reviews, and pipeline surveillanceSearch across publications, patents, clinical trials, and drug labels in a single interface, with precision retrieval at the section levelWorks immediately across all major AI platforms \u2013 no specialist setup requiredDimensions Analytics MCP<\/p>\n

Dimensions Analytics MCP gives AI assistants access to one of the world’s largest linked research databases, spanning publications, grants, patents, clinical trials, datasets, and more.\u00a0<\/p>\n

Map competitive research landscapes across any therapeutic area, geography, or technology domainProfile research organizations and investigators, aggregating publications, grants, and funding relationships automaticallyTrack funding trends and identify top funders, award sizes, and grant activity across any topic or institutionLink research outputs, people, organizations, and funding sources in a single query \u2013 without manually consulting multiple databasesConnecting AI to authoritative research data<\/p>\n

Sebastian Schmidt, EVP Enterprise at Digital Science, said: \u201cResearch-intensive organizations have invested significantly in AI \u2013 the models, the workflows, the infrastructure. What they need is an authoritative bridge between AI and research intelligence. Our new Dimensions MCP integrations do exactly that. Whether a team is mapping the competitive landscape, identifying technology transfer opportunities, tracking IP developments, or scanning the horizon for emerging research trends, their AI agents can now draw on live, structured data from Dimensions \u2013 one of the world\u2019s largest interconnected global research databases. That\u2019s a meaningful shift for enterprise teams making high-stakes decisions.\u201d<\/p>\n

Peter Haase, VP Knowledge Graph Technologies at Digital Science, said: \u201cDimensions Semantic Search MCP is designed specifically for the complexity of life science terminology. A traditional keyword search for ‘PFAS’ only finds documents containing that exact term. Semantic search, by contrast, identifies the underlying scientific concept and uses domain ontologies to recognize the substances that belong to that concept, such as PFOS, PFOA, PFHxS, and others. Rather than relying on users to anticipate every relevant term, abbreviation, or naming variation, the system searches at the level of meaning represented by the ontology. For teams involved in drug discovery, medical affairs, biotechnology, or regulatory intelligence, that difference is significant. It enables researchers to find scientific evidence based on concepts rather than keywords, bringing search closer to the way domain experts think about a subject.\u201d<\/p>\n

Discover more about our Dimensions MCP integrations<\/a><\/p>\n

About Dimensions<\/p>\n

Part of Digital Science, Dimensions hosts the one of the world\u2019s largest collections of interconnected global research data, re-imagining research discovery with access to grants, publications, clinical trials, patents and policy documents all in one place. Follow Dimensions on Bluesky<\/a>, X<\/a> and LinkedIn<\/a>.<\/p>\n

About Digital Science<\/p>\n

Digital Science is a technology company providing innovative solutions to complex challenges faced by researchers, universities, governments, funders, industry, and publishers. We work in partnership to advance global research for the benefit of society. Through our brands \u2013 Altmetric, Dimensions, Figshare, IFI CLAIMS Patent Services, metaphacts, Overleaf, ReadCube, Symplectic, and Writefull \u2013 we believe when we solve problems together, we drive progress for all. Visit digital-science.com and follow Digital Science on Bluesky<\/a>, on X<\/a> or on LinkedIn<\/a>.<\/p>\n

Media contact<\/p>\n

David Ellis, Manager, Media & PR, Digital Science: Mobile +61 447 783 023, [email\u00a0protected]<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Newswise \u2014 Digital Science, a leading technology company serving stakeholders across the research ecosystem, today announced the launch…\n","protected":false},"author":2,"featured_media":135653,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[405,25,7537,67304,11643,375,67305,373,1721,134],"class_list":["post-135652","post","type-post","status-publish","format-standard","has-post-thumbnail","category-agentic-ai","tag-ai-agents","tag-artificial-intelligence","tag-artificial-intelligence-agents","tag-artificial-intelligenceaiartificial-intelligence-aimcpmodel-context-protocolbibliometricspharmaceuticalbiotechbiotechnologyresearch-dataresearch-database","tag-biotech","tag-clinical-trials","tag-digital-science-and-research-solutions-ltd","tag-newswise","tag-pharmaceuticals","tag-technology"],"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/posts\/135652","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/comments?post=135652"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/posts\/135652\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/media\/135653"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/media?parent=135652"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/categories?post=135652"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/tags?post=135652"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}